Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001091818-24-000049
Filing Date
2024-05-03
Accepted
2024-05-03 09:41:15
Documents
35
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QTR. REPORT MARCH 31, 2024 bfnh20240331_10q.htm   iXBRL 10-Q 237182
2 CHIEF EXECUTIVE OFFICER ex311.htm EX-31.1 7118
3 CHIEF FINANCIAL OFFICER ex312.htm EX-31.2 6972
4 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 ex321.htm EX-32.1 3493
5 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 ex322.htm EX-32.2 3530
11 GRAPHIC bfnhlogo2019001.jpg GRAPHIC 21193
  Complete submission text file 0001091818-24-000049.txt   1403531

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bfnh-20240331.xsd EX-101.SCH 10837
7 XBRL CALCULATION FILE bfnh-20240331_cal.xml EX-101.CAL 18437
8 XBRL DEFINITION FILE bfnh-20240331_def.xml EX-101.DEF 18842
9 XBRL LABEL FILE bfnh-20240331_lab.xml EX-101.LAB 101712
10 XBRL PRESENTATION FILE bfnh-20240331_pre.xml EX-101.PRE 74051
38 EXTRACTED XBRL INSTANCE DOCUMENT bfnh20240331_10q_htm.xml XML 75129
Mailing Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454
Business Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454 757-306-6090
BIOFORCE NANOSCIENCES HOLDINGS, INC. (Filer) CIK: 0001310488 (see all company filings)

EIN.: 852138858 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51074 | Film No.: 24911104
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)